"10.1371_journal.pone.0086558","plos one","2014-01-27T00:00:00Z","Hanneke de Waal; Cornelis J Stam; Marieke M Lansbergen; Rico L Wieggers; Patrick J G H Kamphuis; Philip Scheltens; Fernando Maest√∫; Elisabeth C W van Straaten","Alzheimer Center & Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands; Department of Clinical Neurophysiology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands; Nutricia Research, Utrecht, The Netherlands; Laboratory of Cognitive and Computational Neuroscience, UCM-UPM Center for Biomedical Technology, Madrid, Spain","Conceived and designed the experiments: CJS PS PK RW. Performed the experiments: HdW ECWvS ML FM. Analyzed the data: HdW ECWvS MML. Wrote the paper: HW ECWvS MML FM CJS PS PK RW. Designed software used in analysis: CJS.","HW and FM have no conflicts of interest to declare. CS is employed by the VU University Medical Center and is unpaid advisor for Danone Research. ML, RW, and PK are employees of Danone Research. PS is employed by VU University Medical Center, Amsterdam. The Alzheimer Center VU University Medical Center receives unrestricted funding from Danone Research and he is a member of the Nutricia Advisory Board. ES is employed by VU University Medical Center, Amsterdam, and takes part in the clinical neurophysiologic part of the Souvenaid related studies for which VU University Medical Center receives funding from Danone Research. Nutricia has filed an international patent application (PCT) on March 4, 2013, which has been attributed the filing number PCT/NL2013/5050135, and which claims the priority of two PCT applications filed earlier respectively on March 2nd, 2012 and July 6, 2012, under the filing numbers PCT/NL2012/050129 and PCT/NL2012/050487, respectively. The three applications are entitled Method for improving functional synaptic connectivity. Although the product is not claimed, the three applications relate to the use of Souvenaid. Note that all are patent applications and have not been published yet. The authors declare receipt of funding from the commercial source Danone Research. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","01","Hanneke de Waal","HDW",8,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
